Evolving Collagen Aesthetics

Continuously Evolving Collagen Aesthetics

BRAND STORY

The global leader in collagen aesthetics, injecting infinite possibilities into modern life.

Founded in 2001, SUNMAX was established by scientists from a U.S. biotech medical materials company. The research team broke through technological barriers in collagen medical materials, developing a patented collagen purification platform. As Asia’s first GMP medical material manufacturer to successfully mass-produce medical-grade collagen solution, our products are clinically applied in Taiwan, Mainland China, the EU, Southeast Asia, and other countries, setting the benchmark for injection-based medical aesthetics in the Asia-Pacific region.

With exceptional quality and technology, SUNMAX has received multiple recognitions, including the National Medical Quality Award and the National Innovation Award. Moving forward, SUNMAX will continue advancing and innovating to become a global leader in collagen aesthetics.

OUR VALUE

LEAP Mindset

Sunmax upholds the 'LEAP Innovation Mindset,' driving growth and transformation in the collagen industry through technological leadership, continuous evolution, academic collaboration, and professional dedication.

Tech+Leading Leadership & Pioneering

As Asia’s first GMP medical material manufacturer producing medical-grade collagen solution, we continually innovate technologically to lead the global field of collagen aesthetics.

Product+EvolvingProgression & Evolution

Focusing on porcine-derived collagen applied in medical aesthetics, dentistry, and orthopedics, constantly innovating to provide premium products for consumers and partners.

Partner+Academic Education & Learning

Through collaboration with academic partners and the Sunmax Medical Aesthetic Institute's co-learning platform, we empower each other by sharing knowledge, enhancing research capabilities, and promoting product applications.

Team+Professional Professionalism & Focus

Our professional team focuses on the research, production, and application of collagen, providing customers with safe and reliable aesthetic solutions.

OUR KNOWHOW

Sunmax Transformative Technology

SUNMAX Exclusive Technologies

High BiocompatibilityTelopeptides Removal
Technique

Immensely reduces the possibility of triggering allergies and immunogenicity.

Noticeable FirmnessFiber
Reconstitution

Efficiently condenses collagen into tightly packed fiber bundles, ensuring immediate and stable contour results.

Long-Lasting BeautyDual Cross-linking
Technique

Enhances the stability and sustainability for a longer duration and collagen regeneration.

HISTORY

The Road to
Exceptional Collagen

Milestones

2023
  • Collagen Implants Officially Launched in Singapore.
  • SUNMAX Collagen Implants have achieved nearly 2 million units of clinical usage in the Asia-Pacific region.
2022
  • Published a comprehensive educational book, The Untold Secrets of Collagen.
  • New facility at the Southern Taiwan Science Park (STSP) and applied QMS certification for medical device manufacturing.
2020
  • Listed among the Top 100 Fast-Growing Companies by CommonWealth Magazine. SUNMAX Biotech has been recognized as one of the industry's leading growth enterprises, thanks to its outstanding performance and innovative capabilities.
2019
  • Third-generation collagen implants received sales approval in China. SUNMAX continues to innovate and expand into the Chinese market with leading technology and exceptional quality.
2017
  • Honored with the National Innovation Award. SUNMAX’s superior quality and technology have consistently earned recognition through prestigious awards.
2014
  • Third-generation collagen implants obtained sales approval in Taiwan.
  • Fourth-generation collagen implants, featuring triple crosslinking technology, secured multiple international patents.
2012
  • Officially listed on the Taiwan OTC Exchange.
  • Second-generation collagen implants received sales approval in Mainland China.
2009
  • First-generation collagen implants received sales approval in Mainland China. SUNMAX is steadily advancing its international presence with innovative technology and exceptional quality.
2008
  • Second-generation collagen implants obtained sales approval in Taiwan. SUNMAX continuously innovates its technology to deliver more efficient solutions for the medical aesthetics field.
2006
  • First-generation collagen implants obtained sales approval in Taiwan. SUNMAX leverages exceptional technology and innovation to continually lead the development of the medical aesthetics field.
2004
  • SUNMAX's Tainan Science Park facility has obtained GMP certification for medical devices, ensuring that products meet international quality standards and guarantee customer safety.
2001
  • Establishment of SUNMAX Biotech and its collagen production facility at the Southern Taiwan Science Park.